Caller Debbie has gotten her dog with lymphoma through chemo, and he is in remission. But she has some questions after someone recommended that she put her dog on ivermectin as a follow-up to chemo.
Oncologist Brooke Britton weighs in with the issues with the limited research on ivermectin and cancer, plus the very real risks of giving this drug for extended periods of time or at high doses.
Related Links:
What to Know About Lymphoma podcast episode
Tanovea: The First FDA-Approved Dog Lymphoma Treatment podcast episode
Monepantel: A Future Treatment for Dog Lymphoma podcast episode
Chapters:
0:00 Start
2:31 Ivermectin Not Helpful for Lymphoma
5:12 High Doses Are Toxic
11:21 Repurposing Drugs
13:08 MDR1 Mutation
13:41 Ivermectin is Not Appropriate for Dog Cancer
About Today’s Guest, Dr. Brooke Britton:
Brooke Britton completed her residency training in Medical Oncology at the University of Pennsylvania in 2012, and has been in clinical practice in the NYC and Jersey Shore area since that time. She helmed the Brooklyn and Downtown arms of the Oncology Department for BluePearl Veterinary Partners in New York for the past 9 years, and was an active participant in house officer training and clinical trials during her tenure there. She currently serves as a private consultant and maintains an independent clinical practice. Dr. Britton has lectured nationally and authored several peer-reviewed articles. She has particular interest in hematologic malignancies and the metastatic cascade.
LinkedIn
Other Links:
If you would like to ask a dog cancer related question for one of our expert veterinarians to answer on a future Q&A episode, call our Listener Line at 808-868-3200. 
Dog Cancer News is a free weekly newsletter that contains useful information designed to help your dog with cancer. To sign up, please visit DogCancerNews.com 
Learn more about your ad choices. Visit megaphone.fm/adchoices